Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Net Income (2020 - 2025)

Historic Net Income for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to -$2.3 million.

  • Journey Medical's Net Income rose 313.81% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.6 million, marking a year-over-year increase of 5308.68%. This contributed to the annual value of -$14.7 million for FY2024, which is 28079.42% down from last year.
  • Journey Medical's Net Income amounted to -$2.3 million in Q3 2025, which was up 313.81% from -$3.8 million recorded in Q2 2025.
  • In the past 5 years, Journey Medical's Net Income ranged from a high of $16.8 million in Q3 2023 and a low of -$21.8 million during Q4 2021
  • For the 5-year period, Journey Medical's Net Income averaged around -$5.4 million, with its median value being -$4.1 million (2025).
  • Per our database at Business Quant, Journey Medical's Net Income crashed by 3681034.48% in 2021 and then soared by 26655.75% in 2023.
  • Quarter analysis of 5 years shows Journey Medical's Net Income stood at -$21.8 million in 2021, then surged by 51.07% to -$10.6 million in 2022, then soared by 79.86% to -$2.1 million in 2023, then skyrocketed by 173.82% to $1.6 million in 2024, then plummeted by 246.33% to -$2.3 million in 2025.
  • Its last three reported values are -$2.3 million in Q3 2025, -$3.8 million for Q2 2025, and -$4.1 million during Q1 2025.